Table 2.

Standardized^a 10-year Mortality Risk Differences and Hazard Ratios and by Race/Ethnicity and sex, 10 017 HIV-Infected Adults, 1998–2011

	Observed			Standardizeda
	No. Deaths	No. Person-years	10-year Mortality Risk, %	10-year Mortality Risk, %	Risk Difference, % (95% CI)	Risk Ratio (95% CI)	Hazard Ratio (95% CI)
Overall	1224	51,121.1	20.2	20.2	…	…	…
Race/ethnicity/sex
Black women	207	6,730.0	25.0	25.8	7.9 (3.9, 12.0)	1.44 (1.21, 1.72)	1.57 (1.32, 1.87)
Black men	458	13,338.4	27.0	25.2	7.2 (4.3, 10.1)	1.40 (1.23, 1.61)	1.53 (1.33, 1.76)
White men	405	21,792.3	16.8	18.0	0	1	1
Hispanic men	86	5,924.6	12.5	14.8	−3.2 (−7.1, .8)	0.82 (.63, 1.08)	0.82 (.64, 1.05)
White women	53	2,482.0	17.5	13.9	−4.0 (−8.5, .4)	0.77 (.57, 1.05)	0.85 (.61, 1.19)
Hispanic women	15	853.9	12.0	10.8	−7.1 (−16.1, 1.9)	0.61 (.26, 1.42)	0.68 (.37, 1.23)
Race/ethnicity
White	458	24,274.3	16.9	17.2	0	1	1
Black	665	20,068.4	26.3	25.4	8.2 (5.6, 10.8)	1.48 (1.30, 1.67)	1.29 (1.12, 1.49)
Hispanic	101	6,778.5	12.5	14.5	−2.7 (−6.6, 1.1)	0.84 (.65, 1.09)	0.75 (.59, .96)
Sex
Men	949	41,055.3	19.7	19.8	0	1	1
Women	275	10,065.8	22.2	22.0	2.2 (−0.7, 5.2)	1.11 (.97, 1.28)	0.95 (.82, 1.10)

Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus; No., number.

^a Standardized for calendar date of therapy initiation, age at therapy initiation, CD4 cell count (cells/mm³) and HIV-1 RNA plasma concentration (viral load) (log₁₀ copies/mL) most proximate to therapy initiation measured between 6 months prior to 14 days after therapy initiation, antiretroviral therapy naivety (ie, no evidence of prior exposure to mono or dual therapy), prior AIDS diagnosis, history of injection drug use, and history of hepatitis C virus infection; additionally, race/ethnicity risk was standardized for sex and sex risk was standardized for race/ethnicity.